
Results
13
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
13 companies
Bonesupport Holding
Market Cap: SEK 13.0b
An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.
BONEX
SEK 197.20
7D
-6.8%
1Y
-41.9%
Egetis Therapeutics
Market Cap: SEK 2.1b
A pharmaceutical company, focuses on projects in late-stage development for the treatment of serious diseases with unmet medical needs in the orphan drug segment.
EGTX
SEK 5.28
7D
-14.6%
1Y
-2.8%
Genovis AB (publ.)
Market Cap: SEK 1.3b
Develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia.
GENO
SEK 20.30
7D
-3.8%
1Y
-26.4%
Devyser Diagnostics
Market Cap: SEK 1.7b
Engages in the development, manufacture, and sale of diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia.
DVYSR
SEK 105.00
7D
-7.6%
1Y
-21.1%
IDL Diagnostics
Market Cap: SEK 96.8m
A vitro diagnostics company, manufactures and sells IVD tests for oncological and bacterial diseases in Sweden.
IDLDX
SEK 0.42
7D
2.4%
1Y
1.9%
Klaria Pharma Holding AB (publ.)
Market Cap: SEK 137.7m
A pharmaceutical company develops and commercializes medication for migraine and cancer related pain, and opioid overdose and anaphylactic shock.
KLAR
SEK 0.56
7D
15.5%
1Y
24.7%
Xbrane Biopharma
Market Cap: SEK 195.4m
A biotechnology company, engages in the development, manufacture, and sale of biosimilars.
XBRANE
SEK 9.49
7D
-8.6%
1Y
-62.6%
Diamyd Medical
Market Cap: SEK 1.3b
Develops precision medicine therapies for the treatment of autoimmune diabetes.
DMYD B
SEK 9.12
7D
-11.3%
1Y
-24.4%
IRLAB Therapeutics
Market Cap: SEK 192.0m
IRLAB Therapeutics AB (publ) discovers and develops drugs for the treatment of Parkinson’s disease and other CNS disorders.
IRLAB A
SEK 2.26
7D
-5.0%
1Y
-82.2%
Lipum
Market Cap: SEK 305.5m
A biopharmaceutical company, engages in the discovery and development of treatment for chronic inflammatory diseases in Sweden.
LIPUM
SEK 14.40
7D
30.9%
1Y
-14.8%
Guard Therapeutics International
Market Cap: SEK 27.1m
A pharmaceutical company, identifies, develops, and commercializes therapies for the diagnosis and treatment of acute kidney injuries in Sweden.
GUARD
SEK 1.35
7D
-11.5%
1Y
-93.3%
Mendus
Market Cap: SEK 268.9m
A biopharmaceutical company, develops immunotherapies for the treatment of tumor recurrence and established tumors.
IMMU
SEK 5.30
7D
-10.2%
1Y
-42.7%
Swedencare
Market Cap: SEK 5.6b
Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.
SECARE
SEK 35.25
7D
-1.0%
1Y
-21.6%